Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoreline in women with confirmed endometriosis
2013-000798-59Phase 3Active
- Sponsor
- Novalon S.A
- Start
- May 2016
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of goserelin in endometriosis, sponsored by Novalon S.A. Primary endpoints: Responder rate for estradiol suppression and Estradiol suppression by Day 29 and maintenance through Day 85. Started May 2016; status: active.
02
Drugs
goserelin
03
Conditions
endometriosis
Beyond the preview
Go deeper on 2013-000798-59.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000798-59.